Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A M Bergman

Showing results (1-10 of 42) with videos related to

Pageof 5
Sort By:
Endocrine-Related Cancer|April 6, 2018
Androgen receptor moonlighting in the prostate cancer microenvironmentB Cioni, W Zwart, A M Bergman
European Journal of Pharmacology|April 3, 2001
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cellsA M Bergman, H M Pinedo, G J Peters
Urologia Internationalis|March 11, 2010
Pim1 regulates androgen-dependent survival signaling in prostate cancer cellsH G van der Poel, J Zevenhoven, A M Bergman
The Review of Scientific Instruments|March 3, 2010
Development and operation of research-scale III-V nanowire growth reactorsM D Schroer, S Y Xu, A M Bergman, et al.
Magnetic Resonance in Medicine|December 24, 1997
19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridineS K Holland, A M Bergman, Y Zhao, et al.
Nucleosides & Nucleotides|August 5, 1999
Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase?A M Bergman, G Cristalli, S Vittori, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell linesA M Bergman, H M Pinedo, G Veerman, et al.
Physics in Medicine and Biology|January 15, 2010
Monte Carlo calculation of dose distribution in early stage NSCLC patients planned for accelerated hypofractionated radiation therapy in the NCIC-BR25 protocolV Moiseenko, M Liu, A M Bergman, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell linesA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Synergistic interaction between cisplatin and gemcitabine in vitroA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
Pageof 5

Showing results (1-10 of 42) with videos related to

Sort By:
Pageof 5
Endocrine-Related Cancer|April 6, 2018
Androgen receptor moonlighting in the prostate cancer microenvironmentB Cioni, W Zwart, A M Bergman
European Journal of Pharmacology|April 3, 2001
Steroids affect collateral sensitivity to gemcitabine of multidrug-resistant human lung cancer cellsA M Bergman, H M Pinedo, G J Peters
Urologia Internationalis|March 11, 2010
Pim1 regulates androgen-dependent survival signaling in prostate cancer cellsH G van der Poel, J Zevenhoven, A M Bergman
The Review of Scientific Instruments|March 3, 2010
Development and operation of research-scale III-V nanowire growth reactorsM D Schroer, S Y Xu, A M Bergman, et al.
Magnetic Resonance in Medicine|December 24, 1997
19F NMR monitoring of in vivo tumor metabolism after biochemical modulation of 5-fluorouracil by the uridine phosphorylase inhibitor 5-benzylacyclouridineS K Holland, A M Bergman, Y Zhao, et al.
Nucleosides & Nucleotides|August 5, 1999
Biological activity of 1-deazapurine nucleosides: role of deoxycytidine kinase?A M Bergman, G Cristalli, S Vittori, et al.
Advances in Experimental Medicine and Biology|May 23, 1998
Increased sensitivity to gemcitabine of P-gP and MRP overexpressing human non-small cell lung cancer cell linesA M Bergman, H M Pinedo, G Veerman, et al.
Physics in Medicine and Biology|January 15, 2010
Monte Carlo calculation of dose distribution in early stage NSCLC patients planned for accelerated hypofractionated radiation therapy in the NCIC-BR25 protocolV Moiseenko, M Liu, A M Bergman, et al.
Advances in Experimental Medicine and Biology|January 1, 1994
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell linesA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 1996
Synergistic interaction between cisplatin and gemcitabine in vitroA M Bergman, V W Ruiz van Haperen, G Veerman, et al.
Pageof 5